Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case-control analysis
about
A review of the methods used to define glucocorticoid exposure and risk attribution when investigating the risk of fracture in a rheumatoid arthritis populationTreatment of rheumatoid arthritis-associated interstitial lung disease: a perspective reviewA systematic review and meta-analysis regarding the use of corticosteroids in septic arthritisEffects of biological and non-biological immunomodulatory therapies on the immunogenicity of vaccines in patients with rheumatic diseasesSpanish Rheumatology Society and Hospital Pharmacy Society Consensus on recommendations for biologics optimization in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritisTargeting Low Disease Activity in Elderly-Onset Rheumatoid Arthritis: Current and Future Roles of Biological Disease-Modifying Antirheumatic DrugsWhat is the impact of biologic therapies on common co-morbidities in patients with rheumatoid arthritis?Increased Risk of Acute Pancreatitis in Patients with Rheumatoid Arthritis: A Population-Based Cohort StudyWhat evidence is there for a delay in diagnostic coding of RA in UK general practice records? An observational study of free textCommon Infections in Patients Prescribed Systemic Glucocorticoids in Primary Care: A Population-Based Cohort StudyIncidence of giant cell arteritis and characteristics of patients: data-driven analysis of comorbidities.Corticosteroid Risk Function of Severe Infection in Primary Immune Thrombocytopenia Adults. A Nationwide Nested Case-Control Study.Infections in non-splenectomized persistent or chronic primary immune thrombocytopenia adults: risk factors and vaccination effect.Exploring the heterogeneity of effects of corticosteroids on acute respiratory distress syndrome: a systematic review and meta-analysis.Association of baseline steroid use with long-term rates of infection and sepsis in the REGARDS cohortThe value of glucocorticoid co-therapy in different rheumatic diseases--positive and adverse effectsBiomarkers predicting a need for intensive treatment in patients with early arthritisPrognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study.A large two-centre study in to rates of influenza and pneumococcal vaccination and infection burden in rheumatoid arthritis in the UK.Use of corticosteroids in patients with rheumatoid arthritis treated with infliximab: treatment implications based on a real-world Canadian population.Half of U.K. patients with rheumatoid arthritis are prescribed oral glucocorticoid therapy in primary care: a retrospective drug utilisation study.Infection Risk and Safety of Corticosteroid Use.Risk Factors and Outcomes of Nontuberculous Mycobacterial Disease among Rheumatoid Arthritis Patients: A Case-Control study in a TB Endemic AreaRisk of Incident Diabetes Mellitus Associated With the Dosage and Duration of Oral Glucocorticoid Therapy in Patients With Rheumatoid ArthritisOral glucocorticoid therapy and all-cause and cause-specific mortality in patients with rheumatoid arthritis: a retrospective cohort studyAnncaliia algerae microsporidial myositis.Risk and severity of herpes zoster in patients with rheumatoid arthritis receiving different immunosuppressive medications: a case-control study in Asia.Rheumatoid arthritis patients are not at increased risk for 30-day cardiovascular events, infections, or mortality after total joint arthroplasty.The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment.Infectious complications in juvenile idiopathic arthritis.Rheumatoid arthritis in the elderly in the era of tight control.The intelligent use of systemic glucocorticoids in rheumatoid arthritis.When and for how long should glucocorticoids be used in rheumatoid arthritis? International guidelines and recommendations.Optimizing perioperative outcomes for older patients with rheumatoid arthritis undergoing arthroplasty: emphasis on medication management.Practical Management of Respiratory Comorbidities in Patients with Rheumatoid Arthritis.Using Multiple Pharmacovigilance Models Improves the Timeliness of Signal Detection in Simulated Prospective Surveillance.Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force.AP-VAS 2012 case report: a case of ANCA-negative crescentic glomerulonephritis complicating multiple opportunistic infections in the digestive tract.Stress Dose Steroids: Myths and Perioperative Medicine.Martingale residual-based method to control for confounders measured only in a validation sample in time-to-event analysis.
P2860
Q26748556-DBDE554B-EDF4-4F8E-AFED-08F62690A451Q26775753-145A5E53-A6C1-4E08-A954-B30C2262D328Q26783984-25847AD5-FD7A-4266-AB3D-BFC864C7C02BQ26825440-1CB7EE0F-8F46-4840-800B-6DEE4D6AE825Q26852081-DDE4431F-7911-45CE-8D9E-AE51727E961FQ28073436-079F4CA6-148D-4472-88A4-CF89291E3673Q28074148-7508E703-911B-499B-AD87-1E06A768839BQ28547162-08AE0EB0-06C1-469B-93AB-75558B0CA6F4Q28596818-4767086F-DC50-4C3B-9EEC-60C9F2940226Q28602277-FBBE7667-4522-4541-A071-EE2AE40245F9Q30843370-E13BE577-CE04-4449-BC83-CBAA9B44837CQ33427488-238A978D-C534-4257-BEC5-E3565AC41CDEQ33438334-EDCE2DB7-E8BB-4FBD-B413-423FC5FB161CQ33750310-9ACD0900-E566-4C2F-B8A6-BF6E5E16314AQ33901429-8A4BC7BD-5648-40A4-BBD8-644137D570F6Q34597321-C0288A07-752F-4698-B265-AA1FA093EB32Q34982012-2B2E66F7-FFB7-48EF-B8B9-FDDE2C85638DQ35080086-88D6C52E-56F1-465E-8172-86A0D907A2CEQ36095259-763D207B-F83F-4971-9261-1AE88D7EA888Q36182373-8BBAE20C-33FA-40DD-8963-55B545CF5C43Q36477420-1CD3027A-EA73-46AE-B835-1E7BB9E8B94BQ36574609-17F5F0AE-AAC3-4643-A75A-7601E93EEAA1Q37086326-B171C4F6-2EC8-4164-93E7-FEE978515B20Q37169479-5BF0B95C-729F-46FF-891A-58D04EF7FEDBQ37341911-08C2FFCE-B499-4E87-9EEA-1C6513E0193DQ37513492-F97663F4-3FA4-4282-B159-FFAAE46FA585Q37576833-2891A027-A15E-4718-9326-2AF487B1AA70Q37689791-A8B25DD2-68A4-439F-B5F9-4D6EB1801E51Q38063474-4C4AFEE2-0ED3-4B4D-A31D-42D5C2D3FF2BQ38093095-E13A9DBB-97AF-4FEB-AC24-1CB6B55E0F3CQ38150731-8C96968F-F314-4A5F-801F-3839ABB6E394Q38168952-BD20D6AA-D13D-4B64-9F7A-5BB6FC070EEFQ38211695-4C17E048-51F1-4F46-AFB5-F45A28031E92Q38458992-88FE3C2A-D077-4C66-A4FB-900715882FADQ38642378-F6E76072-964B-4B22-90D3-A48162B4EF23Q38701074-0AA33B42-EA1D-4721-9EAE-09F7BF4152EAQ38757421-FA38C366-13DF-4E07-BCFE-8285FFFC7B74Q38783499-1CD4CC4F-7FEA-4AAE-9251-561B83CD37F0Q38879474-A4129892-74B8-4487-B191-D7CE5181CEBFQ39680759-7BBF4207-7A7C-4522-AA07-D3F2CC5632AD
P2860
Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case-control analysis
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Immediate and delayed impact o ...... a nested case-control analysis
@ast
Immediate and delayed impact o ...... a nested case-control analysis
@en
type
label
Immediate and delayed impact o ...... a nested case-control analysis
@ast
Immediate and delayed impact o ...... a nested case-control analysis
@en
prefLabel
Immediate and delayed impact o ...... a nested case-control analysis
@ast
Immediate and delayed impact o ...... a nested case-control analysis
@en
P2093
P2860
P50
P1476
Immediate and delayed impact o ...... a nested case-control analysis
@en
P2093
Marie-Pierre Sylvestre
Samy Suissa
Sasha Bernatsky
P2860
P304
P356
10.1136/ANNRHEUMDIS-2011-200702
P407
P577
2012-01-12T00:00:00Z